Suppr超能文献

血清治疗流行性脊髓灰质炎 26 例报告。

A REPORT ON THE SERUM TREATMENT OF TWENTY-SIX CASES OF EPIDEMIC POLIOMYELITIS.

机构信息

The Rockefeller Institute for Medical Research, New York, and the Westchester County Isolation Hospital, New York State Board of Health.

出版信息

J Exp Med. 1917 Apr 1;25(4):581-608. doi: 10.1084/jem.25.4.581.

Abstract
  1. Serum taken from recently recovered cases of poliomyelitis may be employed in its treatment and probably yields the best results. 2. When sterile for ordinary bacteria, free of corpuscles and hemoglobin, and when injected by the gravity method, observing well known rules of caution, it may be employed without danger. 3. The serum should be injected both intraspinally and intravenously, the latter either directly or by way of the subcutaneous tissues. 4. The earlier in the course of the disease the serum is employed in suitable doses, the more promise there is of benefit. 5. The action of the serum appears to be more precise and definite in arresting paralysis than in rapidly bringing about its retrogression. 6. The decision to employ the serum should rest upon a clinical examination supported by the results of the microscopic and chemical study of the cerebrospinal fluid. 7. The question of multiple and repeated injections of the serum has not yet been worked out. In the cases here reported and especially in the group in which no paralysis existed at the time of the first injection, the pathologic process either did not progress at all, or where there was extension, as in Cases 14 and 15, the upper segment of the spinal cord became rapidly involved, and was followed by respiratory paralysis and death. Probably in cases in which some degree of muscular weakness develops soon after the injection of serum, reinjection 12 to 24 hours later may be advantageous. The temperature curve may serve to indicate the time for reinjection. 8. The favorable results thus far achieved in human beings by means of the immune serum support and extend those obtained experimentally in monkeys and indicate, as was foreseen, that the milder or less fatal form of poliomyelitis appearing in man is even more amenable to the serum treatment than is the highly fatal disease produced by inoculation in monkeys.
摘要
  1. 从最近痊愈的脊髓灰质炎病例中提取的血清可用于治疗,并且可能产生最佳效果。

  2. 当它对普通细菌无菌、无细胞和血红蛋白,并且按照已知的谨慎注射规则通过重力方法注射时,就可以安全使用。

  3. 血清应通过椎管内和静脉内途径注射,后者可以直接或通过皮下组织途径注射。

  4. 在疾病的早期,在适当剂量下使用血清,其益处的可能性就越大。

  5. 血清的作用在阻止瘫痪方面似乎比迅速使其退行更精确和确定。

  6. 使用血清的决定应基于临床检查,该检查得到脑脊液的显微镜和化学研究结果的支持。

  7. 多次和重复注射血清的问题尚未解决。在本报告的病例中,特别是在第一次注射时不存在瘫痪的病例中,病理过程根本没有进展,或者在第 14 例和第 15 例中出现扩展,脊髓的上半段迅速受累,随后出现呼吸瘫痪和死亡。可能在注射血清后不久就出现某种程度的肌肉无力的情况下,在 12 至 24 小时后再次注射可能是有利的。体温曲线可用于指示再次注射的时间。

  8. 通过免疫血清在人类中迄今取得的良好效果支持并扩展了在猴子中进行的实验结果,并表明,出现在人类中的更温和或致命程度较低的脊髓灰质炎形式比通过猴子接种产生的高度致命疾病更能耐受血清治疗,这正如预见的那样。

相似文献

1
A REPORT ON THE SERUM TREATMENT OF TWENTY-SIX CASES OF EPIDEMIC POLIOMYELITIS.
J Exp Med. 1917 Apr 1;25(4):581-608. doi: 10.1084/jem.25.4.581.
2
THE BEHAVIOR OF BACILLUS LEPRAE IN COLD-BLOODED ANIMALS.
J Exp Med. 1911 May 1;13(5):576-89. doi: 10.1084/jem.13.5.576.
3
EXPERIMENTS WITH POLIOMYELITIS IN THE RABBIT.
J Exp Med. 1916 Apr 1;23(4):461-74. doi: 10.1084/jem.23.4.461.
4
LOCALIZATION OF THE VIRUS AND PATHOGENESIS OF EPIDEMIC POLIOMYELITIS.
J Exp Med. 1914 Sep 1;20(3):249-68. doi: 10.1084/jem.20.3.249.
6
A CONTRIBUTION TO THE BACTERIOLOGY OF ACUTE ANTERIOR POLIOMYELITIS.
J Exp Med. 1917 Jun 1;25(6):789-806. doi: 10.1084/jem.25.6.789.
9
ON THE FORMATION OF PRECIPITATES AFTER THE INTRAVENOUS INJECTION OF SALVARSAN.
J Exp Med. 1911 Jul 1;14(1):83-98. doi: 10.1084/jem.14.1.83.
10
STUDIES ON THE TUBERCULIN REACTION AND ON SPECIFIC HYPERSENSITIVENESS IN BACTERIAL INFECTION.
J Exp Med. 1921 Oct 31;34(5):495-524. doi: 10.1084/jem.34.5.495.

引用本文的文献

3
Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates.
Antib Ther. 2020 May 27;3(2):115-125. doi: 10.1093/abt/tbaa010. eCollection 2020 Apr.
4
Modalities and Mechanisms of Treatment for Coronavirus Disease 2019.
Front Pharmacol. 2021 Feb 8;11:583914. doi: 10.3389/fphar.2020.583914. eCollection 2020.
5
Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma.
J Virol Methods. 2021 Feb;288:114031. doi: 10.1016/j.jviromet.2020.114031. Epub 2020 Dec 1.
6
A review of treatment modalities for Middle East Respiratory Syndrome.
J Antimicrob Chemother. 2016 Dec;71(12):3340-3350. doi: 10.1093/jac/dkw338. Epub 2016 Sep 1.
7
EXPERIMENTAL STUDY OF A HORSE ANTIPOLIOMYELITIC SERUM.
J Exp Med. 1931 Jan 1;53(1):123-35. doi: 10.1084/jem.53.1.123.
9
THERAPEUTIC EXPERIMENTS WITH ROSENOW'S ANTIPOLIOMYELITIC SERUM.
J Exp Med. 1918 Feb 1;27(2):309-17. doi: 10.1084/jem.27.2.309.

本文引用的文献

1
LOCALIZATION OF THE VIRUS AND PATHOGENESIS OF EPIDEMIC POLIOMYELITIS.
J Exp Med. 1914 Sep 1;20(3):249-68. doi: 10.1084/jem.20.3.249.
2
THE RELATION TO THE BLOOD OF THE VIRUS OF EPIDEMIC POLIOMYELITIS.
J Exp Med. 1914 Mar 1;19(3):223-33. doi: 10.1084/jem.19.3.223.
3
THE EFFECT OF INTRASPINOUS INJECTIONS OF SALVARSAN AND NEOSALVARSAN IN MONKEYS.
J Exp Med. 1913 Oct 1;18(4):428-34. doi: 10.1084/jem.18.4.428.
4
EXPERIMENTAL EPIDEMIC POLIOMYELITIS IN MONKEYS.
J Exp Med. 1910 Mar 14;12(2):227-55. doi: 10.1084/jem.12.2.227.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验